Metabolomics in lung cancer

S. Okamoto, K. Kobayashi, S. Nishiumi, M. Yoshida, Y. Nishimura (Japan)

Source: Annual Congress 2010 - Biomarkers for lung cancer

Session: Biomarkers for lung cancer
Session type: Thematic Poster Session
Number: 3252

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Okamoto, K. Kobayashi, S. Nishiumi, M. Yoshida, Y. Nishimura (Japan). Metabolomics in lung cancer. Eur Respir J 2010; 36: Suppl. 54, 3252

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006
Epigenetics and lung cancer Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008
Aerosoltherapy in lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008
Venothromboembolism in lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 601s Year: 2007
Epigenetics in IPF and lung cancer Source: Research Seminar 2015 Year: 2015
Screening for lung cancer Source: International Congress 2017 – Lung cancer for the pulmonologist Year: 2017
Lung cancer or cancer of the lung: a view from the bridge Source: Virtual Congress 2020 – Lung cancer or cancer of the lung Year: 2020
Lung cancer Source: School Course 2014 - Pulmonary Rehabilitation Year: 2014
Lung cancer Source: Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term) Year: 2020
Lung cancer Source: Breathe 2016; 12: 392-399 Year: 2016